{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T13:57:01Z","timestamp":1787579821793,"version":"build-2736575974"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-025-04597-8","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T13:42:49Z","timestamp":1756215769000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Advancements in mesenchymal stromal cells for treating connective tissue disease-associated interstitial lung disease: from basic research to clinical application"],"prefix":"10.1186","volume":"16","author":[{"given":"Jiao","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Lin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5258-6881","authenticated-orcid":false,"given":"Jin-fang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"issue":"10354","key":"4597_CR1","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S0140-6736(22)01052-2","volume":"400","author":"M Wijsenbeek","year":"2022","unstructured":"Wijsenbeek M, Suzuki A, Maher TM. Interstitial lung diseases. Lancet. 2022;400(10354):769\u201386. https:\/\/doi.org\/10.1016\/S0140-6736(22)01052-2.","journal-title":"Lancet"},{"key":"4597_CR2","doi-asserted-by":"publisher","unstructured":"Fischer A, Strek ME, Cottin V, Dellaripa PF, Bernstein EJ, Brown KK et al. Proceedings of the American College of Rheumatology\/Association of Physicians of Great Britain and Ireland Connective Tissue Disease-Associated Interstitial Lung Disease Summit: A Multidisciplinary Approach to Address Challenges and Opportunities. Arthritis Rheumatol. 2019;71(2):182\u2013195. https:\/\/doi.org\/10.1002\/art.40769","DOI":"10.1002\/art.40769"},{"issue":"5","key":"4597_CR3","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s00408-020-00383-w","volume":"198","author":"N Jeganathan","year":"2020","unstructured":"Jeganathan N, Sathananthan M. Connective tissue Disease-Related interstitial lung disease: prevalence, patterns, predictors, prognosis, and treatment. Lung. 2020;198(5):735\u201359. https:\/\/doi.org\/10.1007\/s00408-020-00383-w.","journal-title":"Lung"},{"issue":"1","key":"4597_CR4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/acr.23589","volume":"71","author":"E Lange","year":"2019","unstructured":"Lange E, Kucharski D, Svedlund S, Svensson K, Bertholds G, Gjertsson I, et al. Effects of aerobic and resistance exercise in older adults with rheumatoid arthritis: A randomized controlled trial. Arthrit Care Res. 2019;71(1):61\u201370. https:\/\/doi.org\/10.1002\/acr.23589.","journal-title":"Arthrit Care Res"},{"issue":"120","key":"4597_CR5","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1183\/09059180.00001111","volume":"20","author":"CJ Schaefer","year":"2011","unstructured":"Schaefer CJ, Ruhrmund DW, Pan L, Seiwert SD, Kossen K. Antifibrotic activities of Pirfenidone in animal models. Eur Respiratory Rev. 2011;20(120):85\u201397. https:\/\/doi.org\/10.1183\/09059180.00001111.","journal-title":"Eur Respiratory Rev"},{"key":"4597_CR6","doi-asserted-by":"publisher","first-page":"639657","DOI":"10.3389\/fcell.2021.639657","volume":"9","author":"S Yang","year":"2021","unstructured":"Yang S, Liu P, Jiang Y, Wang Z, Dai H, Wang C. Therapeutic applications of mesenchymal stromal cells in idiopathic pulmonary fibrosis. Front Cell Dev Biol. 2021;9:639657. https:\/\/doi.org\/10.3389\/fcell.2021.639657.","journal-title":"Front Cell Dev Biol"},{"key":"4597_CR7","doi-asserted-by":"publisher","first-page":"102245","DOI":"10.1016\/j.coph.2022.102245","volume":"65","author":"TM Wilson","year":"2022","unstructured":"Wilson TM, Solomon JJ, Demoruelle MK. Treatment approach to connective tissue disease-associated interstitial lung disease. Curr Opin Pharmacol. 2022;65:102245. https:\/\/doi.org\/10.1016\/j.coph.2022.102245.","journal-title":"Curr Opin Pharmacol"},{"issue":"19","key":"4597_CR8","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1001\/jama.2024.3669","volume":"331","author":"TM Maher","year":"2024","unstructured":"Maher TM. Interstitial lung disease: A review. JAMA. 2024;331(19):1655\u201365. https:\/\/doi.org\/10.1001\/jama.2024.3669.","journal-title":"JAMA"},{"key":"4597_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/1744666X.2024.2407536","volume":"24","author":"F Atzeni","year":"2024","unstructured":"Atzeni F, Alciati A, Gozza F, Masala IF, Siragusano C, Pipitone N. Interstitial lung disease in rheumatic diseases: an update of the 2018 review. Expert Rev Clin Immunol Published Online September. 2024;24:1\u201318. https:\/\/doi.org\/10.1080\/1744666X.2024.2407536.","journal-title":"Expert Rev Clin Immunol Published Online September"},{"issue":"5","key":"4597_CR10","doi-asserted-by":"publisher","first-page":"103056","DOI":"10.1016\/j.autrev.2022.103056","volume":"21","author":"M Akiyama","year":"2022","unstructured":"Akiyama M, Kaneko Y. Pathogenesis, clinical features, and treatment strategy for rheumatoid arthritis-associated interstitial lung disease. Autoimmun Rev. 2022;21(5):103056. https:\/\/doi.org\/10.1016\/j.autrev.2022.103056.","journal-title":"Autoimmun Rev"},{"issue":"2","key":"4597_CR11","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.pulmoe.2020.01.004","volume":"28","author":"RP Oliveira","year":"2022","unstructured":"Oliveira RP, Ribeiro R, Melo L, Grima B, Oliveira S, Alves JD. Connective tissue disease-associated interstitial lung disease. Pulmonology. 2022;28(2):113\u20138. https:\/\/doi.org\/10.1016\/j.pulmoe.2020.01.004.","journal-title":"Pulmonology"},{"issue":"3","key":"4597_CR12","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1165\/rcmb.2016-0121TR","volume":"55","author":"S Kolahian","year":"2016","unstructured":"Kolahian S, Fernandez IE, Eickelberg O, Hartl D. Immune mechanisms in pulmonary fibrosis. Am J Respir Cell Mol Biol. 2016;55(3):309\u201322. https:\/\/doi.org\/10.1165\/rcmb.2016-0121TR.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"10","key":"4597_CR13","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1056\/NEJMra2005230","volume":"383","author":"M Wijsenbeek","year":"2020","unstructured":"Wijsenbeek M, Cottin V. Spectrum of fibrotic lung diseases. N Engl J Med. 2020;383(10):958\u201368. https:\/\/doi.org\/10.1056\/NEJMra2005230.","journal-title":"N Engl J Med"},{"issue":"2","key":"4597_CR14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1136\/annrheumdis-2020-217230","volume":"80","author":"P Spagnolo","year":"2021","unstructured":"Spagnolo P, Distler O, Ryerson CJ, Tzouvelekis A, Lee JS, Bonella F, et al. Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs). Ann Rheum Dis. 2021;80(2):143\u201350. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217230.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"4597_CR15","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/MCP.0000000000001000","volume":"29","author":"TTT Vu","year":"2023","unstructured":"Vu TTT, Brown KK, Solomon JJ. Myositis-associated interstitial lung disease. Curr Opin Pulm Med. 2023;29(5):427\u201335. https:\/\/doi.org\/10.1097\/MCP.0000000000001000.","journal-title":"Curr Opin Pulm Med"},{"issue":"5","key":"4597_CR16","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.3390\/diagnostics12051139","volume":"12","author":"G Sambataro","year":"2022","unstructured":"Sambataro G, Ferrara CA, Spadaro C, Torrisi SE, Vignigni G, Vancheri A, et al. A new method for the assessment of myalgia in interstitial lung disease: association with positivity for Myositis-Specific and Myositis-Associated antibodies. Diagnostics (Basel). 2022;12(5):1139. https:\/\/doi.org\/10.3390\/diagnostics12051139.","journal-title":"Diagnostics (Basel)"},{"issue":"5","key":"4597_CR17","doi-asserted-by":"publisher","first-page":"3480","DOI":"10.1007\/s00330-021-08411-w","volume":"32","author":"A Laporte","year":"2022","unstructured":"Laporte A, Mariampillai K, Allenbach Y, Pasi N, Donciu V, Toledano D, et al. Idiopathic inflammatory myopathies: CT characteristics of interstitial lung disease and their association(s) with myositis-specific autoantibodies. Eur Radiol. 2022;32(5):3480\u20139. https:\/\/doi.org\/10.1007\/s00330-021-08411-w.","journal-title":"Eur Radiol"},{"issue":"3","key":"4597_CR18","doi-asserted-by":"publisher","first-page":"e003121","DOI":"10.1136\/rmdopen-2023-003121","volume":"9","author":"E Zanatta","year":"2023","unstructured":"Zanatta E, Cocconcelli E, Castelli G, Giraudo C, Fraia AS, De Zorzi E, et al. Interstitial lung disease with and without progressive fibrosing phenotype in patients with idiopathic inflammatory myopathies: data from a large multicentric cohort. RMD Open. 2023;9(3):e003121. https:\/\/doi.org\/10.1136\/rmdopen-2023-003121.","journal-title":"RMD Open"},{"key":"4597_CR19","doi-asserted-by":"publisher","first-page":"uxad104","DOI":"10.1093\/cei\/uxad104","volume":"8","author":"L Bai","year":"2023","unstructured":"Bai L, Zhu J, Ma W, Li F, Zhao P, Zhang S. Neutrophil extracellular traps are involved in the occurrence of interstitial lung disease in a murine experimental autoimmune myositis model. Clin Exp Immunol Published Online September. 2023;8:uxad104. https:\/\/doi.org\/10.1093\/cei\/uxad104.","journal-title":"Clin Exp Immunol Published Online September"},{"issue":"11","key":"4597_CR20","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.3390\/jcm11113021","volume":"11","author":"JS Lee","year":"2022","unstructured":"Lee JS, Ghang B, Choi W, Hong S, Kim YG, Lee CK, et al. Expression of inflammatory markers in the muscles of patients with idiopathic inflammatory myopathy according to the presence of interstitial lung disease. J Clin Med. 2022;11(11):3021. https:\/\/doi.org\/10.3390\/jcm11113021.","journal-title":"J Clin Med"},{"issue":"1","key":"4597_CR21","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1007\/s10753-022-01747-5","volume":"46","author":"L Cheng","year":"2023","unstructured":"Cheng L, Li Y, Luo Y, Zhou Y, Wen J, Wu Y, et al. Decreased Th1 cells and increased Th2 cells in peripheral blood are associated with idiopathic inflammatory myopathies patients with interstitial lung disease. Inflammation. 2023;46(1):468\u201379. https:\/\/doi.org\/10.1007\/s10753-022-01747-5.","journal-title":"Inflammation"},{"issue":"1","key":"4597_CR22","doi-asserted-by":"publisher","first-page":"46","DOI":"10.2478\/jtim-2022-0029","volume":"11","author":"H Cao","year":"2023","unstructured":"Cao H, Huang J, Chang J, Zhu Y, Liang J, Sun C, et al. Predictors of progression in idiopathic inflammatory myopathies with interstitial lung disease. J Transl Int Med. 2023;11(1):46\u201356. https:\/\/doi.org\/10.2478\/jtim-2022-0029.","journal-title":"J Transl Int Med"},{"issue":"2","key":"4597_CR23","doi-asserted-by":"publisher","first-page":"267","DOI":"10.55563\/clinexprheumatol\/a4a9ln","volume":"41","author":"W Lyu","year":"2023","unstructured":"Lyu W, Zhou W, Xu Q, Liu X, Liu Y, Zhang Y, et al. Increased serum levels of sCD40L were associated with rapidly progressive interstitial lung disease in idiopathic inflammatory myopathies. Clin Exp Rheumatol. 2023;41(2):267\u201374. https:\/\/doi.org\/10.55563\/clinexprheumatol\/a4a9ln.","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"4597_CR24","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/S2213-2600(19)30480-1","volume":"8","author":"A Perelas","year":"2020","unstructured":"Perelas A, Silver RM, Arrossi AV, Highland KB. Systemic sclerosis-associated interstitial lung disease. Lancet Respiratory Med. 2020;8(3):304\u201320. https:\/\/doi.org\/10.1016\/S2213-2600(19)30480-1.","journal-title":"Lancet Respiratory Med"},{"issue":"144","key":"4597_CR25","doi-asserted-by":"publisher","first-page":"160125","DOI":"10.1183\/16000617.0125-2016","volume":"26","author":"G Bagnato","year":"2017","unstructured":"Bagnato G, Roberts WN, Roman J, Gangemi S. A systematic review of overlapping MicroRNA patterns in systemic sclerosis and idiopathic pulmonary fibrosis. Eur Respir Rev. 2017;26(144):160125. https:\/\/doi.org\/10.1183\/16000617.0125-2016.","journal-title":"Eur Respir Rev"},{"issue":"3","key":"4597_CR26","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s10555-020-09909-3","volume":"39","author":"AA Fitzgerald","year":"2020","unstructured":"Fitzgerald AA, Weiner LM. The role of fibroblast activation protein in health and malignancy. Cancer Metastasis Rev. 2020;39(3):783\u2013803. https:\/\/doi.org\/10.1007\/s10555-020-09909-3.","journal-title":"Cancer Metastasis Rev"},{"key":"4597_CR27","doi-asserted-by":"publisher","unstructured":"Mira-Avendano I, Abril A, Burger CD, Dellaripa PF, Fischer A, Gotway MB et al. Interstitial Lung Disease and Other Pulmonary Manifestations in Connective Tissue Diseases. Mayo Clin Proc. 2019;94(2):309\u2013325. https:\/\/doi.org\/10.1016\/j.mayocp.2018.09.002","DOI":"10.1016\/j.mayocp.2018.09.002"},{"issue":"5","key":"4597_CR28","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1513\/AnnalsATS.201808-565CME","volume":"16","author":"BA Graney","year":"2019","unstructured":"Graney BA, Fischer A. Interstitial pneumonia with autoimmune features. Ann Am Thorac Soc. 2019;16(5):525\u201333. https:\/\/doi.org\/10.1513\/AnnalsATS.201808-565CME.","journal-title":"Ann Am Thorac Soc"},{"issue":"Suppl 126","key":"4597_CR29","first-page":"291","volume":"38","author":"F Luppi","year":"2020","unstructured":"Luppi F, Sebastiani M, Silva M, Sverzellati N, Cavazza A, Salvarani C, et al. Interstitial lung disease in sj\u00f6gren\u2019s syndrome: a clinical review. Clin Exp Rheumatol. 2020;38(Suppl 126):291\u2013300.","journal-title":"Clin Exp Rheumatol"},{"key":"4597_CR30","doi-asserted-by":"publisher","first-page":"105811","DOI":"10.1016\/j.rmed.2019.105811","volume":"159","author":"Y Kamiya","year":"2019","unstructured":"Kamiya Y, Fujisawa T, Kono M, Nakamura H, Yokomura K, Koshimizu N, et al. Prognostic factors for primary sj\u00f6gren\u2019s syndrome-associated interstitial lung diseases. Respir Med. 2019;159:105811. https:\/\/doi.org\/10.1016\/j.rmed.2019.105811.","journal-title":"Respir Med"},{"issue":"9","key":"4597_CR31","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.tips.2020.06.009","volume":"41","author":"N Song","year":"2020","unstructured":"Song N, Scholtemeijer M, Shah K. Mesenchymal stem cell immunomodulation: mechanisms and therapeutic potential. Trends Pharmacol Sci. 2020;41(9):653\u201364. https:\/\/doi.org\/10.1016\/j.tips.2020.06.009.","journal-title":"Trends Pharmacol Sci"},{"key":"4597_CR32","doi-asserted-by":"publisher","first-page":"591065","DOI":"10.3389\/fimmu.2020.591065","volume":"11","author":"S Dabrowska","year":"2021","unstructured":"Dabrowska S, Andrzejewska A, Janowski M, Lukomska B. Immunomodulatory and regenerative effects of mesenchymal stromal cells and extracellular vesicles: therapeutic outlook for inflammatory and degenerative diseases. Front Immunol. 2021;11:591065. https:\/\/doi.org\/10.3389\/fimmu.2020.591065.","journal-title":"Front Immunol"},{"issue":"1","key":"4597_CR33","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1186\/s13287-021-02511-6","volume":"12","author":"L Chen","year":"2021","unstructured":"Chen L, Qu J, Mei Q, Chen X, Fang Y, Chen L, et al. Small extracellular vesicles from menstrual blood-derived mesenchymal stromal cells (MenSCs) as a novel therapeutic impetus in regenerative medicine. Stem Cell Res Ther. 2021;12(1):433. https:\/\/doi.org\/10.1186\/s13287-021-02511-6.","journal-title":"Stem Cell Res Ther"},{"key":"4597_CR34","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.molimm.2021.04.001","volume":"135","author":"K Xu","year":"2021","unstructured":"Xu K, Ma D, Zhang G, Gao J, Su Y, Liu S, et al. Human umbilical cord mesenchymal stem cell-derived small extracellular vesicles ameliorate collagen-induced arthritis via Immunomodulatory T lymphocytes. Mol Immunol. 2021;135:36\u201344. https:\/\/doi.org\/10.1016\/j.molimm.2021.04.001.","journal-title":"Mol Immunol"},{"issue":"7","key":"4597_CR35","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1007\/s10620-018-5082-8","volume":"63","author":"L Lian","year":"2018","unstructured":"Lian L, Huang Q, Zhang L, Qin H, He X, He X, et al. Anti-fibrogenic potential of mesenchymal stromal cells in treating fibrosis in crohn\u2019s disease. Dig Dis Sci. 2018;63(7):1821\u201334. https:\/\/doi.org\/10.1007\/s10620-018-5082-8.","journal-title":"Dig Dis Sci"},{"issue":"17","key":"4597_CR36","doi-asserted-by":"publisher","first-page":"8570","DOI":"10.7150\/thno.62046","volume":"11","author":"L Tong","year":"2021","unstructured":"Tong L, Hao H, Zhang Z, Lv Y, Liang X, Liu Q, et al. Milk-derived extracellular vesicles alleviate ulcerative colitis by regulating the gut immunity and reshaping the gut microbiota. Theranostics. 2021;11(17):8570\u201386. https:\/\/doi.org\/10.7150\/thno.62046.","journal-title":"Theranostics"},{"issue":"4","key":"4597_CR37","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1002\/art.39477","volume":"68","author":"ATJ Maria","year":"2016","unstructured":"Maria ATJ, Toupet K, Bony C, Pirot N, Vozenin MC, Petit B, et al. Antifibrotic, antioxidant, and Immunomodulatory effects of mesenchymal stromal cells in HOCl-Induced systemic sclerosis. Arthritis Rheumatol. 2016;68(4):1013\u201325. https:\/\/doi.org\/10.1002\/art.39477.","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"4597_CR38","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13287-022-02746-x","volume":"13","author":"M Saleh","year":"2022","unstructured":"Saleh M, Fotook Kiaei SZ, Kavianpour M. Application of wharton jelly-derived mesenchymal stromal cells in patients with pulmonary fibrosis. Stem Cell Res Ther. 2022;13(1):71. https:\/\/doi.org\/10.1186\/s13287-022-02746-x.","journal-title":"Stem Cell Res Ther"},{"issue":"13","key":"4597_CR39","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.7150\/ijms.59218","volume":"18","author":"X Chen","year":"2021","unstructured":"Chen X, Wang F, Huang Z, Wu Y, Geng J, Wang Y. Clinical applications of mesenchymal stromal cell-based therapies for pulmonary diseases: an update and concise review. Int J Med Sci. 2021;18(13):2849\u201370. https:\/\/doi.org\/10.7150\/ijms.59218.","journal-title":"Int J Med Sci"},{"issue":"1","key":"4597_CR40","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13287-018-0846-9","volume":"9","author":"S Chen","year":"2018","unstructured":"Chen S, Cui G, Peng C, Lavin MF, Sun X, Zhang E, et al. Transplantation of adipose-derived mesenchymal stromal cells attenuates pulmonary fibrosis of silicosis via anti-inflammatory and anti-apoptosis effects in rats. Stem Cell Res Ther. 2018;9(1):110. https:\/\/doi.org\/10.1186\/s13287-018-0846-9.","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"4597_CR41","first-page":"501","volume":"16","author":"M Moradi","year":"2017","unstructured":"Moradi M, Rezaee MA, Mohammadi M, Rezaie MJ, Jalili A, Rahmani MR. Attenuating effect of Long-term culture of umbilical cord vein mesenchymal stromal cells on pulmonary fibrosis in C57BL\/6 mice. Iran J Allergy Asthma Immunol. 2017;16(6):501\u201310.","journal-title":"Iran J Allergy Asthma Immunol"},{"issue":"7","key":"4597_CR42","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/jbt.21701","volume":"29","author":"EM Fikry","year":"2015","unstructured":"Fikry EM, Safar MM, Hasan WA, Fawzy HM, El-Denshary EEDS. Bone marrow and Adipose-Derived mesenchymal stromal cells alleviate Methotrexate-Induced pulmonary fibrosis in rat: comparison with dexamethasone. J Biochem Mol Toxicol. 2015;29(7):321\u20139. https:\/\/doi.org\/10.1002\/jbt.21701.","journal-title":"J Biochem Mol Toxicol"},{"issue":"1","key":"4597_CR43","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12890-023-02834-5","volume":"24","author":"R Duan","year":"2024","unstructured":"Duan R, Hong CG, Wang X, Lu M, Xie H, Liu ZZ. Olfactory mucosa mesenchymal stromal cells alleviate pulmonary fibrosis via the Immunomodulation and reduction of inflammation. BMC Pulm Med. 2024;24(1):14. https:\/\/doi.org\/10.1186\/s12890-023-02834-5.","journal-title":"BMC Pulm Med"},{"issue":"3","key":"4597_CR44","doi-asserted-by":"publisher","first-page":"262","DOI":"10.15283\/ijsc20002","volume":"14","author":"X Jin","year":"2021","unstructured":"Jin X, Hou J, Zheng K, Wei D, Zhang A, Wang S, et al. Umbilical cord mesenchymal stromal cells for inhibiting the fibrosis and autoimmune development in HOCl-Induced systemic scleroderma mouse model. Int J Stem Cells. 2021;14(3):262\u201374. https:\/\/doi.org\/10.15283\/ijsc20002.","journal-title":"Int J Stem Cells"},{"issue":"5","key":"4597_CR45","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.chest.2016.10.061","volume":"151","author":"MK Glassberg","year":"2017","unstructured":"Glassberg MK, Minkiewicz J, Toonkel RL, Simonet ES, Rubio GA, DiFede D, et al. Allogeneic human mesenchymal stromal cells in patients with idiopathic pulmonary fibrosis via intravenous delivery (AETHER). Chest. 2017;151(5):971\u201381. https:\/\/doi.org\/10.1016\/j.chest.2016.10.061.","journal-title":"Chest"},{"issue":"2","key":"4597_CR46","doi-asserted-by":"publisher","first-page":"00773","DOI":"10.1183\/23120541.00773-2020","volume":"7","author":"A Campo","year":"2021","unstructured":"Campo A, Gonz\u00e1lez-Ruiz JM, Andreu E, Alcaide AB, Oc\u00f3n MM, De-Torres J, et al. Endobronchial autologous bone marrow-mesenchymal stromal cells in idiopathic pulmonary fibrosis: a phase I trial. ERJ Open Res. 2021;7(2):00773\u20132020. https:\/\/doi.org\/10.1183\/23120541.00773-2020.","journal-title":"ERJ Open Res"},{"key":"4597_CR47","doi-asserted-by":"publisher","unstructured":"L M, H H, W X, L H, L J, X B, et al. Clinical investigation on nebulized human umbilical cord MSC-derived extracellular vesicles for pulmonary fibrosis treatment. Signal Transduct Target Therapy. 2025;10(1). https:\/\/doi.org\/10.1038\/s41392-025-02262-3.","DOI":"10.1038\/s41392-025-02262-3"},{"issue":"3","key":"4597_CR48","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s10067-024-06865-z","volume":"43","author":"M Alip","year":"2024","unstructured":"Alip M, Wang D, Zhao S, Li S, Zhang D, Duan X, et al. Umbilical cord mesenchymal stromal cells transplantation in patients with systemic sclerosis: a 5-year follow-up study. Clin Rheumatol. 2024;43(3):1073\u201382. https:\/\/doi.org\/10.1007\/s10067-024-06865-z.","journal-title":"Clin Rheumatol"},{"key":"4597_CR49","doi-asserted-by":"publisher","unstructured":"X HZJL. Sustained benefit from combined plasmapheresis and allogeneic mesenchymal stromal cells transplantation therapy in systemic sclerosis. Arthritis Res Therapy. 2017;19(1). https:\/\/doi.org\/10.1186\/s13075-017-1373-2.","DOI":"10.1186\/s13075-017-1373-2"},{"key":"4597_CR50","doi-asserted-by":"publisher","unstructured":"W Y. Improvement in long-term survival with mesenchymal stem cell transplantation in systemic sclerosis patients: a propensity score-matched cohort study. Stem Cell Res Ther. 2025;16(1). https:\/\/doi.org\/10.1186\/s13287-025-04237-1.","DOI":"10.1186\/s13287-025-04237-1"},{"issue":"2","key":"4597_CR51","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3390\/cells13020160","volume":"13","author":"G Escarrer-Garau","year":"2024","unstructured":"Escarrer-Garau G, Mart\u00edn-Medina A, Truyols-Vives J, G\u00f3mez-Bellvert C, Elowsson L, Westergren-Thorsson G, et al. In vivo and in vitro Pro-Fibrotic response of Lung-Resident mesenchymal stromal cells from patients with idiopathic pulmonary fibrosis. Cells-basel. 2024;13(2):160. https:\/\/doi.org\/10.3390\/cells13020160.","journal-title":"Cells-basel"},{"issue":"2","key":"4597_CR52","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41401-022-00952-0","volume":"44","author":"L Qin","year":"2023","unstructured":"Qin L, Liu N, Bao C le, Yang M, Ma DZ, Yi GX. Mesenchymal stromal cells in fibrotic diseases-the two sides of the same coin. Acta Pharmacol Sin. 2023;44(2):268\u201387. https:\/\/doi.org\/10.1038\/s41401-022-00952-0.","journal-title":"Acta Pharmacol Sin"},{"key":"4597_CR53","doi-asserted-by":"publisher","first-page":"114653","DOI":"10.1016\/j.intimp.2025.114653","volume":"155","author":"F Gao","year":"2025","unstructured":"Gao F, Pan L, Liu W, Chen J, Wang Y, Li Y, et al. Idiopathic pulmonary fibrosis microenvironment: novel mechanisms and research directions. Int Immunopharmacol. 2025;155:114653. https:\/\/doi.org\/10.1016\/j.intimp.2025.114653.","journal-title":"Int Immunopharmacol"},{"key":"4597_CR54","doi-asserted-by":"publisher","first-page":"121731","DOI":"10.1016\/j.biomaterials.2022.121731","volume":"288","author":"H Bao","year":"2022","unstructured":"Bao H, Cheng S, Li X, Li Y, Yu C, Huang J, et al. Functional Au nanoparticles for engineering and long-term CT imaging tracking of mesenchymal stromal cells in idiopathic pulmonary fibrosis treatment. Biomaterials. 2022;288:121731. https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121731.","journal-title":"Biomaterials"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04597-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04597-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04597-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T02:20:46Z","timestamp":1756261246000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-025-04597-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4597"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04597-8","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,26]]},"assertion":[{"value":"13 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Declerations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"457"}}